Table 4 Impact of generic substitution on the marketing of pharmaceutical products in the pharmaceutical companies.
Survey 2004 | Survey 2008 | |||||||
|---|---|---|---|---|---|---|---|---|
Original product companies n (%) | Generic product companies n (%) | Total n (%) | P-value | Original product companies n (%) | Generic product companies n (%) | Total n (%) | P-value | |
Has generic substitution influenced the amount of prescription medicine marketing?* | 0.103 | 1.000 | ||||||
No | 7 (44) | 4 (57) | 11 (48) | 7 (44) | 3 (50) | 10 (45) | ||
Marketing has decreased | 7 (44) | 1 (14) | 8 (35) | 8 (50) | 3 (50) | 11 (50) | ||
Marketing has increased | - | 2 (29) | 2 (9) | 1 (6) | - | 1 (5) | ||
Some other impacta | 2 (12) | - | 2 (9) | - | - | - | ||
Total | 16 (100) | 7 (100) | 23 (100) | 16 (100) | 6 (100) | 22 (100) | ||
Has generic substitution influenced prescription medicine representatives' visits to pharmacies?** | 0.120 | 0.619 | ||||||
No | 9 (60) | 2 (29) | 11 (50) | 10 (62) | 5 (83) | 15 (68) | ||
Visits have decreased | 2 (13) | - | 2 (9) | 2 (13) | 1 (17) | 3 (14) | ||
Visits have increased | 3 (20) | 5 (71) | 8 (36) | 4 (25) | - | 4 (18) | ||
Some other impactb | 1 (7) | - | 1 (5) | - | - | - | ||
Total | 15 (100) | 7 (100) | 22 (100) | 16 (100) | 6 (100) | 22 (100) | ||
Has generic substitution influenced prescription medicine representatives' visits to physicians?*** | 1.000 | 0.802 | ||||||
No | 10 (63) | 5 (71) | 15 (65) | 9 (60) | 4 (67) | 13 (62) | ||
Visits have decreased | 5 (31) | 2 (29) | 7 (31) | 5 (33) | 1 (17) | 6 (29) | ||
Visits have increased | - | - | - | 1 (7) | 1 (17) | 2 (9) | ||
Some other impactc | 1 (6) | - | 1 (4) | - | - | - | ||
Total | 16 (100) | 7 (100) | 23 (100) | 15 (100) | 6 (100) | 21 (100) | ||